Thanks for logging in.

You can now click/tap WATCH to start the live stream.

Thanks for logging in.

You can now click/tap LISTEN to start the live stream.

Thanks for logging in.

You can now click/tap LATEST NEWS to start the live stream.

LISTEN
Watch
on air now

Create a 2GB account today!

You can now log in once to listen live, watch live, join competitions, enjoy exclusive 2GB content and other benefits.


Joining is easy.

Advertisement
Advertisement
Advertisement

Antibodies offer hope to ward off COVID-19

Luke Grant

Professor Chris Goodnow, Medical Research Director at the Garvan Institute, whose scientists have engineered human antibodies that attack SARS-CoV-2. Once optimised, the viral therapy will be tested in human clinical trials by the Kirby Institute and may provide immunity to the coronavirus for both treatment and prevention. Professor Goodnow says he is “very optimistic” that the antibodies would form the basis of a therapy. The first phase of human clinical trials could start towards the later part of this year.

Download this podcast here

Luke Grant
Advertisement